Hm-30181 clinical trials
How each study uses hm-30181 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the hm-30181 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
In one entry with another drug
Given together, or one or the other
- HM30181AK tablet + Irinotecan tablets
- 2
Studies by the year they started
6 studies that test it; most in 2008 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Hanmi Pharmaceutical Company Limited (4) · Health Hope Pharma (2)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test hm-30181.
Studies
Open first, then newest update. How each study uses hm-30181 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Study to Investigate the Effect of Food on the Bioavailability of Oral Paclitaxel Administered With Encequidar in Participants With Advanced Solid TumorsNot yet recruitingPhase 1Health Hope PharmaNCT07580833Written as Oral Paclitaxel in combination with Encequidar tablet
- Oral Paclitaxel + Encequidar vs IV Paclitaxel in Treatment of HER2 Negative Metastatic Breast CancerNot yet recruitingPhase 3Health Hope PharmaNCT06835400Written as Encequidar tablet
- Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102)CompletedPhase 1Hanmi Pharmaceutical Company LimitedNCT00986843Written as HM30181AK tablet + Irinotecan tablets
- Clinical Trial to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of Oral Paclitaxel in Patients With Advanced Solid CancerCompletedPhase 1Hanmi Pharmaceutical Company LimitedNCT01491204Written as Paclitaxel+HM30181
- Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid MalignanciesCompletedPhase 1Hanmi Pharmaceutical Company LimitedNCT00979563Written as HM30181AK tablet + Irinotecan tablets
- Duration of P-glycoprotein Inhibition After Oral Administration of HM30181AK TabletCompletedPhase 1Hanmi Pharmaceutical Company LimitedNCT00954304Written as HM30181AK 1mg
Codes
What other systems call hm-30181 · ClinicalTrials.gg INT017016
- UNII (FDA) K4I4I996O4ENCEQUIDARConfirmed FDA, Wikidata
- Wikidata Q27281950hm-30181Confirmed FDA, Wikidata
- DrugBank DB14070One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | K4I4I996O4 | ENCEQUIDAR | Confirmed FDA, Wikidata |
| Wikidata | Q27281950 | hm-30181 | Confirmed FDA, Wikidata |
| DrugBank | DB14070 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.